Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients (TBIDU)

This study has been completed.
Sponsor:
Collaborators:
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
Information provided by:
National Institute for Health Development, Estonia
ClinicalTrials.gov Identifier:
NCT01290081
First received: February 3, 2011
Last updated: NA
Last verified: January 2008
History: No changes posted

February 3, 2011
February 3, 2011
October 2007
January 2008   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients
Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Tuberculosis
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
  • Active Comparator: Active referral
    Case management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.
    Intervention: Other: Case management approach in referral to health care services
  • No Intervention: Passive referral
    Participants were instructed to schedule an appointment with TB services themselves.
    Intervention: Other: Case management approach in referral to health care services
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
112
January 2008
January 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Participation in substitution treatment program,
  • Age 18 years or more,
  • Able to read and write in Estonian or Russian,
  • Able to provide informed consent
Both
18 Years and older
Not Provided
Contact information is only displayed when the study is recruiting subjects
Estonia
 
NCT01290081
TBIDU-1230
Not Provided
Kristi Rüütel, National Institute for Health Development
National Institute for Health Development, Estonia
  • LLC Corrigo
  • Ida-Viru Central Hospital, Department of Tuberculosis
Not Provided
National Institute for Health Development, Estonia
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP